A Bellis
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 9
-
- Pregnancy and preeclampsia studies 1
- Co-authors
- Elaine Church (1 shared paper)
- Journals
- The Lancet (6 papers)BJOG An International Journal of Obstetrics & Gynaecology (1 paper)EClinicalMedicine (1 paper)The Lancet Diabetes & Endocrinology (1 paper)The Lancet Child & Adolescent Health (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
A Bellis
13 papers receiving 1.6k citations
A Bellis's Hit Papers
Peers
Comparison fields: 5 of 82
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Statistics and Probability 47
- Oncology 75
Countries citing papers authored by A Bellis
This map shows the geographic impact of A Bellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bellis more than expected).
Fields of papers citing papers by A Bellis
This network shows the impact of papers produced by A Bellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bellis. The network helps show where A Bellis may publish in the future.
Co-authors
The 1 scholars most cited alongside A Bellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 2023 | 25 | |
| 8 | 2024 | 24 | |
| 9 | 2006 | 6 | |
| 10 | 2025 | 5 | |
| 11 | 2014 | 3 | |
| 12 | 2025 | 2 | |
| 13 | 2007 | 1 |
About A Bellis
A Bellis is a scholar working on Infectious Diseases, Obstetrics and Gynecology, Rheumatology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health, having authored 13 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Pelvic floor disorders treatments (1 paper), Pregnancy and preeclampsia studies (1 paper), Cardiovascular Issues in Pregnancy (1 paper), Clinical practice guidelines implementation (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Statistics and Probability (47 citations) and Oncology (75 citations). A Bellis has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Elaine Church. Their work appears in journals such as The Lancet, BJOG An International Journal of Obstetrics & Gynaecology, EClinicalMedicine, The Lancet Diabetes & Endocrinology and The Lancet Child & Adolescent Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.